alpha-aminopyridine has been researched along with Dermatofibrosarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahri, N; Czaplinski, JT; Eilers, G; Fletcher, JA; Hornick, JL; Lindeman, NI; MariƱo-Enriquez, A; Mayeda, M; Sicinska, E; Tao, D; Wagner, AJ; Zhu, M | 1 |
1 other study(ies) available for alpha-aminopyridine and Dermatofibrosarcoma
Article | Year |
---|---|
CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.
Topics: Adult; Aged; Aminopyridines; Animals; Blotting, Western; Cell Line, Tumor; Collagen Type I; Collagen Type I, alpha 1 Chain; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p16; Dermatofibrosarcoma; Drug Resistance, Neoplasm; Gene Deletion; Gene Fusion; Humans; Imatinib Mesylate; Mice; Middle Aged; Phosphorylation; Piperazines; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-sis; Purines; Pyridines; Retinoblastoma Protein; RNA Interference; Xenograft Model Antitumor Assays; Young Adult | 2015 |